Details for Patent: 10,568,855

Which drugs does patent 10,568,855 protect, and when does it expire?

Patent 10,568,855 protects PHEXXI and is included in one NDA.

This patent has twenty-four patent family members in fifteen countries.

Summary for Patent: 10,568,855

Title:	Compositions and methods for enhancing the efficacy of contraceptive microbicides
Abstract:	The present disclosure relates to compositions and methods for contraception that also enhance the efficacy of microbicides. Such compositions serve the dual purpose of preventing pregnancy and lessening the risk of spreading sexually transmitted diseases. More specifically, the compositions and methods relate to syngergistic contraceptive microbicide and antiviral compositions comprising a combination of a contraceptive microbicide and an antiviral agent in an acidic carrier that enhances the efficacy of both the contraceptive microbicide and antiviral agent.
Inventor(s):	Wendell Guthrie
Assignee:	Evofem Inc
Application Number:	US16/239,314
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,568,855
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 10,568,855

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Evofem Inc	PHEXXI	citric acid; lactic acid; potassium bitartrate	GEL;VAGINAL	208352-001	May 22, 2020		RX	Yes	Yes	10,568,855					PREVENTION OF PREGNANCY

International Family Members for US Patent 10,568,855

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013274815
Australia	2017206199
Brazil	112014030984